BACKGROUND: The best type of laparoscopic approach in solid liver tumours (SLTs), whether total laparoscopic surgery or hand-assisted laparoscopic surgery (HALS), has not yet been established. Our objective is to present our experience with laparoscopic liver resections in SLTs performed by HALS using a new approach. METHODS: We performed 35 laparoscopic resections in SLTs, of which 26 were carried out using HALS (in 25 patients) and 21 patients had liver metastases of a colorectal origin (LMCRC) (1 patient had 2 resections), 1 metastasis from a neuroendocrine tumour of the pancreas, 1 hepatocarcinoma on a healthy liver, 1 primary hepatic leiomyosarcoma and 1 giant haemangioma. Mean follow-up was 22 months. OPERATION: One right hemihepatectomy, one left hemihepatectomy, five bisegmentectomies II-III, three bisegmentectomies VI-VII and 16 segmentectomies (five of S. VI, three of S. VIII; three of S. V; two of S. IVb; one of S. II; one of S. IV; and in the remaining case resection of S. III and VI plus resection of a metastasis in S. VIII). MAIN OUTCOME MEASURES: Morbidity and mortality, conversion to open procedure, intraoperative blood loss, intra- and postoperative transfusion, length of stay and survival. RESULTS: There were no intra- or postoperative deaths, nor were there any conversions. One patient presented with morbidity (3.8%) (liver abscess). Mean blood loss was 200 ml (range 0-600 ml). One patient required transfusion (3.8%). Mean operative time was 180 min (range 120-360 min). Mean length of hospital stay was 4 days (range 2-5 days). The actuarial survival rate of the patients at 36 months with liver metastases from colorectal carcinoma (LMCRC) was 80%. CONCLUSIONS: Liver resection with HALS reproduces the low morbidity and mortality rates and effectiveness (3-year survival) of open surgery in SLTs when indicated selectively.
BACKGROUND: The best type of laparoscopic approach in solid liver tumours (SLTs), whether total laparoscopic surgery or hand-assisted laparoscopic surgery (HALS), has not yet been established. Our objective is to present our experience with laparoscopic liver resections in SLTs performed by HALS using a new approach. METHODS: We performed 35 laparoscopic resections in SLTs, of which 26 were carried out using HALS (in 25 patients) and 21 patients had liver metastases of a colorectal origin (LMCRC) (1 patient had 2 resections), 1 metastasis from a neuroendocrine tumour of the pancreas, 1 hepatocarcinoma on a healthy liver, 1 primary hepatic leiomyosarcoma and 1 giant haemangioma. Mean follow-up was 22 months. OPERATION: One right hemihepatectomy, one left hemihepatectomy, five bisegmentectomies II-III, three bisegmentectomies VI-VII and 16 segmentectomies (five of S. VI, three of S. VIII; three of S. V; two of S. IVb; one of S. II; one of S. IV; and in the remaining case resection of S. III and VI plus resection of a metastasis in S. VIII). MAIN OUTCOME MEASURES: Morbidity and mortality, conversion to open procedure, intraoperative blood loss, intra- and postoperative transfusion, length of stay and survival. RESULTS: There were no intra- or postoperative deaths, nor were there any conversions. One patient presented with morbidity (3.8%) (liver abscess). Mean blood loss was 200 ml (range 0-600 ml). One patient required transfusion (3.8%). Mean operative time was 180 min (range 120-360 min). Mean length of hospital stay was 4 days (range 2-5 days). The actuarial survival rate of the patients at 36 months with liver metastases from colorectal carcinoma (LMCRC) was 80%. CONCLUSIONS: Liver resection with HALS reproduces the low morbidity and mortality rates and effectiveness (3-year survival) of open surgery in SLTs when indicated selectively.
Authors: Joseph F Buell; Alan J Koffron; Mark J Thomas; Steven Rudich; Michael Abecassis; E Steve Woodle Journal: J Am Coll Surg Date: 2005-03 Impact factor: 6.113
Authors: N Katkhouda; M Hurwitz; J Gugenheim; E Mavor; R J Mason; D J Waldrep; R T Rivera; M Chandra; G M Campos; S Offerman; A Trussler; P Fabiani; J Mouiel Journal: Ann Surg Date: 1999-04 Impact factor: 12.969
Authors: Ricardo Robles; Caridad Marín; Juan Angel Fernández; Pablo Ramírez; Francisco Sánchez-Bueno; Dolores Morales; Juan Antonio Luján; Beatriz Abellán; María Ramírez; Pedro Cascales; Domingo Pérez; Pascual Parrilla Journal: Cir Esp Date: 2005-07 Impact factor: 1.653
Authors: Daniel Cherqui; Alexis Laurent; Claude Tayar; Stephen Chang; Jeanne Tran Van Nhieu; Jérôme Loriau; Mehdi Karoui; Christophe Duvoux; Daniel Dhumeaux; Pierre-Louis Fagniez Journal: Ann Surg Date: 2006-04 Impact factor: 12.969
Authors: Joel W Lewin; Nicholas A O'Rourke; Adrian K H Chiow; Richard Bryant; Ian Martin; Leslie K Nathanson; David J Cavallucci Journal: HPB (Oxford) Date: 2015-12-10 Impact factor: 3.647
Authors: Jose M Ramia; Ignasi Poves; Camilo Castellón; Luis Diez-Valladares; Carmelo Loinaz; Alejandro Serrablo; Miguel A Suarez Journal: World J Surg Date: 2013-10 Impact factor: 3.352
Authors: Michael Tsinberg; Gurkan Tellioglu; Conrad H Simpfendorfer; R M Walsh; Matthew R Walsh; David Vogt; John Fung; Eren Berber Journal: Surg Endosc Date: 2008-12-31 Impact factor: 4.584
Authors: Alvaro Bueno; Fernando Rotellar; Alberto Benito; Pablo Martí-Cruchaga; Gabriel Zozaya; José Hermida; Fernando Pardo Journal: HPB (Oxford) Date: 2013-08-22 Impact factor: 3.647